UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

ISTH guidelines on Lupus Anticoagulant testing

Thrombosis research, 2012-10, Vol.130, p.S76-S77

Pengo, V.

2012

Volltextzugriff (PDF)

ISCHEMIC STROKE AND MAJOR BLEEDING WHILE ON DIRECT ORAL ANTICOAGULANTS IN NAÏVE PATIENTS WITH ATRIAL FIBRILLATION: IMPACT OF RESUMPTION OR DISCONTINUATION OF ANTICOAGULANT TREATMENT. A population-based study

International journal of cardiology, 2024-01, Vol.394, p.131369-131369, Article 131369

2024

Volltextzugriff (PDF)

Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns

Thrombosis research, 2018-12, Vol.172, p.172-178

2018

Volltextzugriff (PDF)

Clinical value of anti-domain I-β2Glycoprotein 1 antibodies in antiphospholipid antibody carriers. A single centre, prospective observational follow-up study

Clinica chimica acta, 2018-10, Vol.485, p.74-78

2018

Volltextzugriff (PDF)

Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial

The Lancet (British edition), 2008-01, Vol.371 (9609), p.315-321

2008

Volltextzugriff (PDF)

Standardized Low―Molecular-Weight Heparin Bridging Regimen in Outpatients on Oral Anticoagulants Undergoing Invasive Procedure or Surgery: An Inception Cohort Management Study

Circulation (New York, N.Y.), 2009-06, Vol.119 (22), p.2920-2927

2009

Volltextzugriff (PDF)

Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry

International journal of cardiology, 2021-03, Vol.327, p.176-182

2021

Volltextzugriff (PDF)

Correct laboratory approach to APS diagnosis and monitoring

Autoimmunity reviews, 2013-06, Vol.12 (8), p.832-834

2013

Volltextzugriff (PDF)

Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study

BJOG : an international journal of obstetrics and gynaecology, 2019-04, Vol.126 (5), p.656-661

2019

Volltextzugriff (PDF)

APS - Diagnostics and challenges for the future

Autoimmunity reviews, 2016-11, Vol.15 (11), p.1031-1033

2016

Volltextzugriff (PDF)

A PK–PD Model for Predicting the Impact of Age, CYP2C9, and VKORC1 Genotype on Individualization of Warfarin Therapy

Clinical pharmacology and therapeutics, 2007-04, Vol.81 (4), p.529-538

2007

Volltextzugriff (PDF)

Antibodies to Domain I of β(2)Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)

Thrombosis research, 2011-12, Vol.128 (6), p.583-586

2011

Volltextzugriff (PDF)

Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy

Thrombosis research, 2009-01, Vol.123 (3), p.482-487

2009

Volltextzugriff (PDF)

Point of Care Testing (POCT) to assess drug concentration in patients treated with non-vitamin K antagonist oral anticoagulants (NOACs)

Thrombosis research, 2018-03, Vol.163, p.100-104

2018

Volltextzugriff (PDF)

Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles

Thrombosis research, 2015-07, Vol.136 (1), p.161-163

2015

Volltextzugriff (PDF)

Residual Venous Obstruction, alone and in Combination with D-Dimer, as a Risk Factor for Recurrence after Anticoagulation Withdrawal following a First Idiopathic Deep Vein Thrombosis in the Prolong Study

European journal of vascular and endovascular surgery, 2010-03, Vol.39 (3), p.356-365

2010

Volltextzugriff (PDF)

Hospitalized patients with atrial fibrillation compared to those included in recent trials on novel oral anticoagulants: A population-based study

European journal of internal medicine, 2013-06, Vol.24 (4), p.318-323

2013

Volltextzugriff (PDF)

OC-15 - Risk factors for cancer development after idiopathic venous thromboembolism

Thrombosis research, 2016-04, Vol.140, p.S174-S174

2016

Volltextzugriff (PDF)

Higher levels of plasma matrix metalloproteinase-2 are associated with a significantly increased risk of arterial thrombosis in patients with the antiphospholipid syndrome

International journal of cardiology, 2012-10, Vol.160 (2), p.149-151

2012

Volltextzugriff (PDF)

Antibodies to oxidized LDL/β2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism

Thrombosis research, 2008, Vol.122 (4), p.556-559

2008

Volltextzugriff (PDF)

Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA)

Thrombosis research, 2010-08, Vol.126 (2), p.150-153

2010

Volltextzugriff (PDF)

APS – controversies in diagnosis and management, critical overview of current guidelines

Thrombosis research, 2011-02, Vol.127, p.S51-S52

Pengo, Vittorio

2011

Volltextzugriff (PDF)

Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function

Thrombosis research, 2009-01, Vol.123 (3), p.444-451

2009

Volltextzugriff (PDF)

Antibodies to Domain I of β2 Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)

Thrombosis research, 2011-12, Vol.128 (6), p.583-586

2011

Volltextzugriff (PDF)

Outcomes with oral anticoagulation resumption or discontinuation after an anticoagulation-related event in patients with atrial fibrillation

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(92)

Publikationsform

Artikel
(93)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(59)
Life Sciences & Biomedicine
(48)
Humans
(41)
Female
(31)
Male
(26)
Biological And Medical Sciences
(23)
Cardiovascular System & Cardiology
(23)
Medical Sciences
(22)
Middle Aged
(22)
Adult
(21)
Hematology
(18)
Aged
(17)
Peripheral Vascular Disease
(16)
Pharmacology. Drug Treatments
(15)
Antiphospholipid Syndrome - Immunology
(13)
Antiphospholipid Syndrome
(12)
Technology
(12)
Aged, 80 And Over
(11)
Thrombosis
(11)
Antiphospholipid Syndrome - Blood
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

ISTH guidelines on Lupus Anticoagulant testing

ISCHEMIC STROKE AND MAJOR BLEEDING WHILE ON DIRECT ORAL ANTICOAGULANTS IN NAÏVE PATIENTS WITH ATRIAL FIBRILLATION: IMPACT OF RESUMPTION OR DISCONTINUATION OF ANTICOAGULANT TREATMENT. A population-based study

Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns

Clinical value of anti-domain I-β2Glycoprotein 1 antibodies in antiphospholipid antibody carriers. A single centre, prospective observational follow-up study

Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial

Standardized Low―Molecular-Weight Heparin Bridging Regimen in Outpatients on Oral Anticoagulants Undergoing Invasive Procedure or Surgery: An Inception Cohort Management Study

Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry

Correct laboratory approach to APS diagnosis and monitoring

Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study

APS - Diagnostics and challenges for the future

A PK–PD Model for Predicting the Impact of Age, CYP2C9, and VKORC1 Genotype on Individualization of Warfarin Therapy

Antibodies to Domain I of β(2)Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)

Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy

Point of Care Testing (POCT) to assess drug concentration in patients treated with non-vitamin K antagonist oral anticoagulants (NOACs)

Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles

Residual Venous Obstruction, alone and in Combination with D-Dimer, as a Risk Factor for Recurrence after Anticoagulation Withdrawal following a First Idiopathic Deep Vein Thrombosis in the Prolong Study

Hospitalized patients with atrial fibrillation compared to those included in recent trials on novel oral anticoagulants: A population-based study

OC-15 - Risk factors for cancer development after idiopathic venous thromboembolism

Higher levels of plasma matrix metalloproteinase-2 are associated with a significantly increased risk of arterial thrombosis in patients with the antiphospholipid syndrome

Antibodies to oxidized LDL/β2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism

Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA)

APS – controversies in diagnosis and management, critical overview of current guidelines

Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function

Antibodies to Domain I of β2 Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)

Outcomes with oral anticoagulation resumption or discontinuation after an anticoagulation-related event in patients with atrial fibrillation

Aktive Filter

Suchergebnisse filtern